Abstract
A 57 year-old Caucasian patient presented to the office asking for evaluation of a full body rash that started approximately 9 weeks ago (Figs. 29.1, 29.2, and 29.3). The patient had a previously diagnosed acinic cancer, a rare salivary gland tumor, arising from his right neck. He had three surgeries for tumor recurrences. His chemotherapy included cisplatin, taxotir, and most recently, cetuximab (Erbitux) for the last 11 weeks. After the first 2 weeks of cetuximab, the patient noticed a pruritic, monomorphous popular and pustular rash spreading over his face, trunk, back, and arms. The lower extremities and the genitals have been spared.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balagula Y, Garbe C, Myskowski PL, Hauschild A, Rapoport BL, Boers-Doets CB, Lacouture ME. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. Int J Dermatol. 2011;50:129–46.
Boggs W. Oral minocycline reduces cetuximab-associated papular rash. J Clin Oncol. 2007;25:5390–6.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Ang KK. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11(1):21–8.
Dancey J, Sausville EA. Issues and progress with protein kinase inhibitors for cancer treatment. Nat Rev Drug Discov. 2003;2:296–313.
DeWitt CA, Siroy AE, Stone SP. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol. 2007;56(3):500–5.
Lenz HJ. Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events. Oncology. 2006;20(5 Suppl 2):5–13.
Lynch TJ, Kim ES, Eaby B, et al. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist. 2007;12:610–21.
Tomková H, Kohoutek M, ZábojnÃková M, PospÃÅ¡ková M, OstřÞková L, Gharibyar M. Cetuximab-induced cutaneous toxicity. J Eur Acad Dermatol Venereol. 2010;24:692–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Norman, R.A., Endo, J. (2013). Full Body Rash. In: Clinical Cases in Geriatric Dermatology. Clinical Cases in Dermatology. Springer, London. https://doi.org/10.1007/978-1-4471-4135-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4135-8_29
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4134-1
Online ISBN: 978-1-4471-4135-8
eBook Packages: MedicineMedicine (R0)